Phototherapy-mediated syndrome of inappropriate secretion of antidiuretic hormone in an in utero selective serotonin reuptake inhibitor-exposed newborn infant

Pediatrics

Volumn 115, Issue 5, 2005, Pages

  Vanhaesebrouck, Piet ^a   De Bock, Freia ^a   Zecic, Alexandra ^a   De Praeter, Claudine ^a   Smets, Koenraad ^a   De Coen, Kris ^a   Goossens, Linde ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Hyponatremia; Neonate; Phototherapy; Selective serotonin reuptake inhibitor; Serotonin syndrome; Syndrome of inappropriate secretion of antidiuretic hormone

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SODIUM; VASOPRESSIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HORMONE METABOLISM; HUMAN; HYPERBILIRUBINEMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LABORATORY TEST; LIVER FUNCTION TEST; NERVE CONDUCTION; PHOTOTHERAPY; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SODIUM BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; NEWBORN; NEWBORN JAUNDICE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; SCHWARTZ BARTTER SYNDROME;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; INFANT, NEWBORN; JAUNDICE, NEONATAL; PHOTOTHERAPY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 23044447596     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2329     Document Type: Article

References (21)

1. Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed. 2001;85:F147-F148
2. Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60:720-726
3. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113:368-375
4. Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor induced hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion in the elderly. Int J Geriatr Psychiatry. 1998;13:12-15
5. Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002;36:1175-1177
6. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53:41-44
7. Neumeister A, Turner EH, Matthews JR, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998;55:524-530
8. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360:1840-1842
9. Hendrick V, Stowe Z, Altshuler L, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medication. Am J Psychiatry. 2003;160:993-996
10. Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol. 2004;7:329-334
11. Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA. 1999;282:1264-1269
12. Goldstein BJ, Goodnick PJ. Selective serotonin reuptake inhibitors in the treatment of affective disorders. Tolerability, safety and pharmacoeconomics. J Psychopharmacol. 1998;12:S55-S87
13. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335:1010-1015
14. Sarrias MJ, Cabre P, Martinez E, Artigas F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem. 1990;54:783-786
15. Casper RC, Barry E, Fleisher BE, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142:402-408
16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245
17. Anderson IK, Martin GR, Ramage AG. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT 2/5-HT1C receptors to release vasopressin in anaesthetized rats. Br J Pharmacol. 1992;107:1020-1028
18. Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI. Drug interactions with newer antidepressants: role of human cytochromes P450. J Clin Psychiatry. 1998;59:19-27
19. Swiecicki L, Szafranski T. Side effects after phototherapy implementation in addition to fluoxetine or sertraline treatment: a report of two cases. World J Biol Psychiatry. 2002;3:109-111
20. Benedetti F, Colombo C, Pontiggia A, Bernasconi A, Florita M, Smeraldi E. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry. 2003;64:648-653
21. Zammarchi E, La Rosa S, Pierro U, Lenzi G, Bartolini P, Falorni S. Free tryptophan decrease in jaundiced infants during phototherapy. Biol Neonate. 1989;55:224-227